Skip to main content
Cannara Biotech Inc. (TSX:LOVE)
Canada flag Canada · Delayed Price · Currency is CAD
1.770
-0.010 (-0.56%)
Apr 28, 2026, 3:55 PM EST

Cannara Biotech Revenue

Cannara Biotech had revenue of 27.15M CAD in the quarter ending February 28, 2026, with 2.60% growth. This brings the company's revenue in the last twelve months to 113.01M, up 20.13% year-over-year. In the fiscal year ending August 31, 2025, Cannara Biotech had annual revenue of 107.20M with 31.14% growth.

Revenue (ttm)
113.01M
Revenue Growth
+20.13%
P/S Ratio
1.55
Revenue / Employee
250.03K
Employees
452
Market Cap
174.84M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Aug 31, 2025107.20M25.45M31.14%
Aug 31, 202481.75M24.49M42.77%
Aug 31, 202357.26M21.42M59.76%
Aug 31, 202235.84M18.82M110.58%
Aug 31, 202117.02M14.47M567.24%
Aug 31, 2020 Pro Pro Pro
Aug 31, 2019 Pro Pro Pro
Aug 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BioSyent 43.05M
Charlotte's Web Holdings 68.41M
Auxly Cannabis Group 151.48M
Ascend Wellness Holdings 686.36M
HLS Therapeutics 76.10M
Grown Rogue International 44.46M
Medexus Pharmaceuticals 136.34M
Aurora Cannabis 373.12M
Revenue Rankings

Cannara Biotech News

More News